Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
University of British Columbia
$105,000.00
Long-term health resource utilization and total economic burden following diagnosis of Systemic Autoimmune Rheumatic Diseases: a population-based study
EF 2013-14
Résumé
SARDs are a group of inflammatory arthritis disorders (including lupus) affecting muscles, joints, and nearly every body system. Life span and quality are reduced by serious damage to the lungs, brain, heart, blood vessels and kidneys that frequently occurs, and the toxic effects of their immunosuppressive therapies. Thus, SARDs are believed quite costly to the healthcare system, but the long-term costs of these chronic disorders, and what influences them, are not well known. We will access 16 years of anonymous medical claims (including outpatient visits & tests, hospitalizations, and all prescriptions) for all adult SARD patients in BC, no matter where they live, to calculate their medical costs over time. To determine the extra healthcare costs from SARDs, we will compare these costs to those for a similar group of BC residents without SARDs. The physical manifestations of SARDs mean patients frequently are limited in their ability to participate in childcare, domestic activities and paid work during their prime reproductive and career years. In fact, many SARD patients become unable to work within 2 years of diagnosis, barring further career advancement and eliminating a source of retirement savings, extended health benefits, socialization and self-esteem. The financial implications for patients, families and the entire Canadian economy are huge, but underappreciated, and what drives these costs is unknown. We will directly survey a sample of the same BC SARD patients about their quality-of-life, and time they are less, or completely unable, to work or perform other activities, and link this data to their health claims data to quantify the total economic burden of SARDs. Our estimates should raise the profile of SARDs in Canada and help policymakers allocate scarce government resources to deliver care more efficiently and make informed decisions about new therapies, to reduce costs, keep patients working, and help preserve their health and quality-of-life
Programme
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
307772
Name
McCormick Natalie
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Musculoskeletal Health and Arthritis
Theme2
Social / Cultural / Environmental / Population Health
Prcname2
Doctoral Research Awards - B
Projecttitle
Long-term health resource utilization and total economic burden following diagnosis of Systemic Autoimmune Rheumatic Diseases: a population-based study
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Connective Tissue Disorders; Direct Medical Costs; Health Economics; Indirect Costs; Longitudinal Analysis; Population-Based Cohort; Productivity Costs; Provincial Administrative Data; Systemic Autoimmune Rheumatic Diseases; Systemic Vasculitis
Abstract
SARDs are a group of inflammatory arthritis disorders (including lupus) affecting muscles, joints, and nearly every body system. Life span and quality are reduced by serious damage to the lungs, brain, heart, blood vessels and kidneys that frequently occurs, and the toxic effects of their immunosuppressive therapies. Thus, SARDs are believed quite costly to the healthcare system, but the long-term costs of these chronic disorders, and what influences them, are not well known. We will access 16 years of anonymous medical claims (including outpatient visits & tests, hospitalizations, and all prescriptions) for all adult SARD patients in BC, no matter where they live, to calculate their medical costs over time. To determine the extra healthcare costs from SARDs, we will compare these costs to those for a similar group of BC residents without SARDs. The physical manifestations of SARDs mean patients frequently are limited in their ability to participate in childcare, domestic activities and paid work during their prime reproductive and career years. In fact, many SARD patients become unable to work within 2 years of diagnosis, barring further career advancement and eliminating a source of retirement savings, extended health benefits, socialization and self-esteem. The financial implications for patients, families and the entire Canadian economy are huge, but underappreciated, and what drives these costs is unknown. We will directly survey a sample of the same BC SARD patients about their quality-of-life, and time they are less, or completely unable, to work or perform other activities, and link this data to their health claims data to quantify the total economic burden of SARDs. Our estimates should raise the profile of SARDs in Canada and help policymakers allocate scarce government resources to deliver care more efficiently and make informed decisions about new therapies, to reduce costs, keep patients working, and help preserve their health and quality-of-life
Competitiondate
201310
Approvedterm2
3 yrs 0 mth
Pinamesdelim
McCormick, Natalie
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~